
Sign up to save your podcasts
Or
Meet Edupression A Vienna-based App on Prescription
Find all options to subscribe to our newsletter, podcast, YouTube channel or listen to our internet radio station here: Link https://linktr.ee/startupradio
In this interview, we talk to Daniel Amann (https://www.linkedin.com/in/daniel-amann-4a1b0711a/), the CEO and Co-Founder of Edupression (https://edupression.com/). Edupression is an anti-depression app from the greater Vienna area. Daniel has a background in financial services, where he held a lot of different positions with companies like Allianz or Raiffeisen International. One of his friends committed suicide, which drew his attention to depression.
So, he co-founded Edupression.
Get scouted by us, when we have a matching mandate and enroll your startup in our database: https://forms.gle/DmPtBKJH7MMmJoYo8
We don’t sell your data or spam you. We will even reach out to you before we include you in a scouting mandate.
In total the founding team of Edupression (https://edupression.com/) are 4 co-founders, which spent approx. three years working on Edupression before the interview, including advice from the Medical University Vienna (https://en.wikipedia.org/wiki/MedicalUniversityof_Vienna).
Edupression is a certified medical product, as a stand alone therapy for mild to medium depression symptoms, stand alone or in combination with drugs or psychotherapy. The company plans to have the app available on prescription in January 2022 in Germany and Austria.
Apple’s App Store (https://apps.apple.com/app/id1562982041)
Google Play Store (https://play.google.com/store/apps/details?id=com.proappdev.edupressionwebmobile_app)
Edupression is currently looking to raise Series A funding for its international expansion in 2022. They would like to close the round end of 2021 or early in 2022.
Find all links and show notes here: https://www.startuprad.io/blog/meet-edupression-a-vienna-based-app-on-prescription/
---
Send in a voice message: https://anchor.fm/deeptechgermany/message
Meet Edupression A Vienna-based App on Prescription
Find all options to subscribe to our newsletter, podcast, YouTube channel or listen to our internet radio station here: Link https://linktr.ee/startupradio
In this interview, we talk to Daniel Amann (https://www.linkedin.com/in/daniel-amann-4a1b0711a/), the CEO and Co-Founder of Edupression (https://edupression.com/). Edupression is an anti-depression app from the greater Vienna area. Daniel has a background in financial services, where he held a lot of different positions with companies like Allianz or Raiffeisen International. One of his friends committed suicide, which drew his attention to depression.
So, he co-founded Edupression.
Get scouted by us, when we have a matching mandate and enroll your startup in our database: https://forms.gle/DmPtBKJH7MMmJoYo8
We don’t sell your data or spam you. We will even reach out to you before we include you in a scouting mandate.
In total the founding team of Edupression (https://edupression.com/) are 4 co-founders, which spent approx. three years working on Edupression before the interview, including advice from the Medical University Vienna (https://en.wikipedia.org/wiki/MedicalUniversityof_Vienna).
Edupression is a certified medical product, as a stand alone therapy for mild to medium depression symptoms, stand alone or in combination with drugs or psychotherapy. The company plans to have the app available on prescription in January 2022 in Germany and Austria.
Apple’s App Store (https://apps.apple.com/app/id1562982041)
Google Play Store (https://play.google.com/store/apps/details?id=com.proappdev.edupressionwebmobile_app)
Edupression is currently looking to raise Series A funding for its international expansion in 2022. They would like to close the round end of 2021 or early in 2022.
Find all links and show notes here: https://www.startuprad.io/blog/meet-edupression-a-vienna-based-app-on-prescription/
---
Send in a voice message: https://anchor.fm/deeptechgermany/message
230 Listeners
1 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners
0 Listeners